Bio-Techne
TECH
#1491
Rank
A$18.80 B
Marketcap
$118.36
Share price
1.09%
Change (1 day)
13.54%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2023 (TTM): $2.36

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is $2.53. In 2022 the company made an earnings per share (EPS) of $2.69 an increase over its 2021 EPS that were of $2.16.

EPS history for Bio-Techne from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.36-12.2%
2022$2.6924.35%
2021$2.1617.98%
2020$1.83-10.94%
2019$2.06101.57%
2018$1.02-17.53%
2017$1.2439.37%
2016$0.89-17.23%
2015$1.07-14.97%
2014$1.261.29%
2013$1.253.68%
2012$1.20-1.97%
2011$1.231.67%
2010$1.217.14%
2009$1.13-1.06%
2008$1.1419.41%
2007$0.9519.1%
2006$0.8010.56%
2005$0.7229.5%
2004$0.5613.05%
2003$0.4968.43%
2002$0.29-17.05%
2001$0.3517.33%
2000$0.3048.51%
1999$0.2023.17%
1998$0.1613.89%
1997$0.1442.57%
1996$0.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$24.69 877.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$9.21-464.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.93 253.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.91 410.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.34-7.38%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$13.76 444.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.51-159.87%๐Ÿ‡บ๐Ÿ‡ธ USA